Modulation of one of the most important blood cells involved in the human immune response may effectively treat and prevent the symptoms of type 2 diabetes and periodontitis simultaneously, scientists say. Researchers have found that B cells, blood cells involved in the human immune response, promote inflammation and bone loss in type 2 diabetes-associated periodontal disease. These findings support the idea that treatments that manipulate the responses of B cells may treat or prevent this complication. "Our study identified common inflammatory mechanisms shared by type 2 diabetes and periodontal disease. It paves the way for the development of novel therapeutics which aim to simultaneously treat both type 2 diabetes and its complications," said Min Zhu, a researcher involved in the work from the department of microbiology at Boston University School of Medicine in Boston, Massachusetts. To make this discovery, scientists used an experimental model (mouse model) of periodo...
India's largest auto maker Tata Motors on March 03, 2009 unveiled the European version of Nano, touted as the world's cheapest car --Nano-Europa-- in the 79th Geneva Motor Show. "We plan to bring Nano to Europe because we think there is a market for low-cost cars in Europe, which have good fuel economy," Tata Group Chairman Ratan Tata told. Tata said Nano-Europa would come with airbags and other high-end features, "but it will still be a low-cost car".
ReplyDelete